喷他佐辛注射液获得研制立项批件 Pentazocine inj approved of developmemt
On September 13, 2018, Maxmind Pharma was granted approval for the development of narcotic drugs and psychotropic drugs by CFDA, agreeing to the import of Pentazocin injection from India.
As a kind of synthetic opioid, Pentazoxine injection is a analgesic and anesthetic assistant drug of clinical need .At present, only CR Double Crane pharmaceutical co., ltd. has been approved for production and sales in China, which was launched in 1998, and has not passed the generic drug consistency evaluation.
The product is manufactured according to BP and USP, while adopting WHO GMP, is an advanced generic consistent with the reference product both in quality and efficacy, will greatly improve the clinical benefit of the patients.
Our company has been preparing the registration dossier, and expected to make the submission within the year.